Advancing our innovative pipeline
to address unmet needs

Archived Publications

TransCon Growth Hormone

Baseline Demographics of the TransCon Growth Hormone Phase 3 heiGHt Trial

M. Beckert, D.B. Karpf, A. Shu, Z. Lin, J.A. Leff. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, March 17-20, 2018 (Chicago, IL).

Pediatric Phase 2 Data Demonstrate That TransCon hGH Has an Anti-hGH Immunogenic Profile That Is Comparable to Daily hGH

D. Gilfoyle, S. Pihl, P. Chatelain, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

A Six-Month Safety and Efficacy Study of TransCon hGH Compared to Daily hGH in Prepubertal Children with Growth Hormone Deficiency (GHD)

P. Chatelain, O. Malievsky, K. Radziuk, G. Senatorova, M. Beckert. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Design and Clinical Development of TransCon Growth Hormone for Growth Hormone Deficiency

M. Beckert, D. Gilfoyle, J.M. Mikkelsen, et al. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

Pharmacokinetic Modelling Predicts Native hGH Levels Following Administration of a Sustained-release Prodrug, TransCon hGH, to Children With GHD

K. Sprogøe, M. Beckert, E.D. Christoffersen, D. Gilfoyle, T. Wegge. Poster presented at 55th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), September 10-12, 2016 (Paris, France).

TransCon PTH

TransCon PTH for Hypoparathyroidism – Design and Preliminary Results of a Phase 1 TransCon PTH Trial in Healthy Adults

D.B. Karpf, S. Pihl, E. Mortensen, K. Sprogøe, J.A. Leff. Poster presented at the Endocrine Society (ENDO) Annual Meeting and Expo, March 17-20, 2018 (Chicago, IL).

Back to Top